This NIHR Collection brings together major studies on the prevention and treatment of childhood eczema. It finds that many ...

Despite multiple treatments for eczema and pityriasis alba, a child’s skin condition worsened until a biopsy revealed mycosis ...

Eczema is an umbrella term for a group of conditions that result in skin irritation and inflammation. The most common form of ...

Contrary to some commonly held beliefs, current research shows that cutting out certain foods makes little difference in ...

Everyone’s eczema is different. Common triggers include stress, sweat, certain chemicals, dust, and pollen. Some foods can trigger flares in infants and children. A symptom diary can help you tr ...

Once-daily roflumilast cream 0.05 percent is safe and effective for atopic dermatitis (AD) in patients ages 2 to 5 ye ...

It’s unclear what happens first. In babies and children, eczema can be an early sign of allergy risk. Eczema and allergies are both triggered by an abnormal immune response. The immune system ...

Eczema typically appears in early childhood, impacting approximately 25% of children, per the AAD. However, there are adults who develop chronic adult-onset eczema in their 30s, 40s, 50s and beyond.

NIH researchers define diagnostic criteria for topical steroid withdrawal (TSW), distinguishing it from eczema.

Soothing eczema involves hydration, avoiding triggers, and stress management. Dermatology-approved treatments and following gentle skincare tips can help control symptoms and promote healthier, ...

Once-daily roflumilast cream 0.05% is safe and effective for atopic dermatitis (AD) in patients ages 2 to 5 years, according to a study published online Feb. 20 in Pediatric Dermatology.